Drug intelligence / Profile preview

SOLX

Development stage
Phase 1
Lead developer
Hemerus Medical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

SOLX is a proprietary red-blood-cell additive and storage solution, also called **AS-7**, used within the SOLX whole-blood collection and leukoreduction system. It is supplied as two additive-solution components that are combined with prepared red blood cells to support refrigerated storage. The associated FDA-approved system is used to prepare leukocyte-reduced CPD/AS-7 red blood cells and plasma products; red blood cells prepared with AS-7 may be stored at 1–6 °C for up to 42 days under the labeled U.S. conditions. SOLX is a blood-component processing and preservation product rather than a conventional disease-directed therapeutic. ([fda.gov](https://www.fda.gov/media/85744/download?attachment=))

Brand names
SOLX
Other names
AS-7AS7AS 7AS-7 Additive SolutionAS7 Additive SolutionAS 7 Additive SolutionSOLX Additive Solution

Beyond the preview

Go deeper on SOLX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOLX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call